Examining association between early treatment with tocilizumab, risk of death among critically ill COVID-19 patients

(JAMA Network) Whether treatment with tocilizumab in the first two days after being admitted to an intensive care unit was associated with a reduced risk of death among critically ill patients with COVID-19 was investigated in this study.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news